DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Smith MR. et al.
Denosumab and bone metastasis-free survival in men with nonmetastatic castration-resistant prostate cancer: exploratory analyses by baseline prostate-specific antigen doubling time.
J Clin Oncol 2013;
31: 3800-3806
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.